Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

被引：0

作者：

Jennifer Landsberg

Judith Kohlmeyer

Marcel Renn

Tobias Bald

Meri Rogava

Mira Cron

Martina Fatho

Volker Lennerz

Thomas Wölfel

Michael Hölzel

Thomas Tüting

机构：

[1] Laboratory of Experimental Dermatology,Department of Dermatology and Allergy

[2] University of Bonn,Third Department of Medicine

[3] D-53105 Bonn,Department of Clinical Chemistry and Clinical Pharmacology

[4] Germany,undefined

[5] Haematology/Oncology/Pneumology,undefined

[6] University Medical Centre of the Johannes Gutenberg University,undefined

[7] D-55101 Mainz,undefined

[8] Germany,undefined

[9] Unit for RNA Biology,undefined

[10] University of Bonn,undefined

[11] D-53105 Bonn,undefined

[12] Germany,undefined

来源：

Nature | 2012年 / 490卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A genetically engineered mouse model is used to determine the mechanism of acquired resistance to adoptive therapy with cytotoxic T cells specific for a melanocytic differentiation antigen; tumour necrosis factor (TNF)-α is identified as a crucial factor that causes reversible dedifferentiation of mouse and human melanoma cells.

引用

页码：412 / 416

页数：4

共 50 条

[41] Antiviral T-cell therapy
Leen, Ann M.
Heslop, Helen E.
Brenner, Malcolm K.
IMMUNOLOGICAL REVIEWS, 2014, 258 (01) : 12 - 29
[42] T-cell therapy at the threshold
June, Carl
Rosenberg, Steven A.
Sadelain, Michel
Weber, Jeffrey S.
NATURE BIOTECHNOLOGY, 2012, 30 (07) : 611 - 614
[43] T-cell lymphoma gene fusion augments T-cell therapy
Green, Kathleen J.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (07) : 1420 - 1420
[44] T-cell gene therapy
Hege, KM
Roberts, MR
CURRENT OPINION IN BIOTECHNOLOGY, 1996, 7 (06) : 629 - 634
[45] T-cell therapy for cancer
Barrett, John
Bollard, Catherine M.
IMMUNOTHERAPY, 2012, 4 (04) : 347 - 350
[46] T-Cell Therapy to the Rescue
Pepple, Kathryn L.
Van Gelder, Russell N.
OPHTHALMOLOGY RETINA, 2021, 5 (09): : 835 - 837
[47] T-cell therapy at the threshold
Carl June
Steven A Rosenberg
Michel Sadelain
Jeffrey S Weber
Nature Biotechnology, 2012, 30 : 611 - 614
[48] Adoptive T-cell therapy
Lokhorst, HM
Liebowitz, D
SEMINARS IN HEMATOLOGY, 1999, 36 (01) : 26 - 29
[49] T-cell gene therapy
Hege, K. M.
Roberts, M. R.
Current Opinion in Biotechnology, 7 (06):
[50] CAR T-cell therapy
Cookson, Emma
LANCET HAEMATOLOGY, 2022, 9 (05): : E322 - E322

← 1 2 3 4 5 →